This topic contains a solution. Click here to go to the answer

Author Question: What is the recommended time period for using the nicotine patch to quit smoking? A) 1 to 3 weeks ... (Read 89 times)

ghost!

  • Hero Member
  • *****
  • Posts: 560
What is the recommended time period for using the nicotine patch to quit smoking?
 
  A) 1 to 3 weeks
  B) 1 to 2 months
  C) 9 to 10 weeks
  D) 4 to 6 months

Question 2

Irritability, nausea, vomiting, and headache are typical symptoms of
 
  A) emphysema.
  B) chronic bronchitis.
  C) nicotine cravings.
  D) nicotine withdrawal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

itsakadoozi

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

C

Answer to Question 2

D




ghost!

  • Member
  • Posts: 560
Reply 2 on: Jul 12, 2018
Gracias!


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library